Table 2.
Antimicrobial resistance pattern of Salmonella Typhiisolates in Siloam Hospital, Karawaci, Tangerang, Banten, Indonesia.
| Antimicrobial | 2011 (n = 14) |
2012 (n = 16) |
2013 (n = 17) |
2014 (n = 27) |
2015 (n = 19) |
Total (n = 93) |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | n | % | |
| AMP | 2 | 14.3 | 2 | 12.5 | 1 | 5.9 | 0 | 0.0 | 0 | 0.0 | 5 | 5.4 |
| AMC | 1 | 7.2 | 1 | 6.3 | 1 | 5.9 | 0 | 0.0 | 0 | 0.0 | 3 | 3.2 |
| CRO | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| CT | 2 | 14.3 | 1 | 6.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 3 | 3.2 |
| MER | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 3.7 | 0 | 0.0 | 1 | 1.1 |
| IPM | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 3.7 | 0 | 0.0 | 1 | 1.1 |
| TMP-SMX | 5 | 35.7 | 1 | 6.3 | 1 | 5.9 | 1 | 3.7 | 0 | 0.0 | 8 | 8.6 |
| AMP + TMP-SMX | 2 | 14.3 | 1 | 6.3 | 1 | 5.9 | 0 | 0.0 | 0 | 0.0 | 4 | 4.3 |
| CIP | 0 | 0.0 | 1 | 6.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 1.1 |
| LEVX | 0 | 0.0 | 1 | 6.3 | 1 | 5.9 | 1 | 3.7 | 0 | 0.0 | 3 | 3.2 |
AMP, ampicillin; AMC, amoxicillin clavulanate; CRO, ceftriaxone; CT, cefotaxime; MER, meropenem; IPM, imipenem; TMP-SMX, trimethoprim-sulfamethoxazole; AKN, amikacin; GEN, gentamicin; CIP, ciprofloxacin; LEVX, levofloxacin.